Lixte Biotechnology Holdings, Inc. (LIXT) NASDAQ

2.83

+0.81(+40.10%)

Updated at July 03 04:00PM

Currency In USD

Valuation

Market Cap4.57M
Enterprise Value3.53M
P/E Ratio-2.1
PEG Ratio-0.24
Price/Sales Ratio0
Price/Book Ratio6.03
Enterprise/Revenue0
Enterprise/EBITDA-1.45

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-2.2
Return On Equity-2.37

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-3.57M
Net Income-3.59M
Diluted EPS-1.59

Balance Sheet

Total Cash1.38M
Total Cash/Share0.56
Total Debt0
Total Debt/Equity0
Current Ratio3.9
Book Value Per Share0.47

Price History

52-Week Change28.64
52-Week High4.25
52-Week Low0.64
Moving Average 50 Days1.22
Moving Average 200 Days1.65

Statistics

Average Volume870,172
Shares Outstanding2.68M
% Held by Institutions1.49

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateJune 05, 2023